Katoh H, Ishikawa S
J Hum Genet. 2021; 66(9):887-899.
PMID: 34267306
PMC: 8384627.
DOI: 10.1038/s10038-021-00960-8.
Corso G, Montagna G, Figueiredo J, La Vecchia C, Romario U, Fernandes M
Cancers (Basel). 2020; 12(6).
PMID: 32560361
PMC: 7352390.
DOI: 10.3390/cancers12061598.
Suzuki A, Katoh H, Komura D, Kakiuchi M, Tagashira A, Yamamoto S
Sci Adv. 2020; 6(19):eaav9778.
PMID: 32426482
PMC: 7202881.
DOI: 10.1126/sciadv.aav9778.
Shin S, Kim Y, Lee J, Lee K
J Cancer. 2020; 11(1):208-212.
PMID: 31892987
PMC: 6930413.
DOI: 10.7150/jca.36513.
Guindalini R, Cormedi M, Maistro S, Pasini F, Branas P, Dos Santos L
Gastric Cancer. 2019; 22(5):920-931.
PMID: 30895400
PMC: 6694034.
DOI: 10.1007/s10120-019-00945-9.
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.
Lee K, Krempely K, Roberts M, Anderson M, Carneiro F, Chao E
Hum Mutat. 2018; 39(11):1553-1568.
PMID: 30311375
PMC: 6188664.
DOI: 10.1002/humu.23650.
Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer.
Melo S, Figueiredo J, Fernandes M, Goncalves M, Morais-de-Sa E, Sanches J
Int J Mol Sci. 2017; 18(12).
PMID: 29231860
PMC: 5751289.
DOI: 10.3390/ijms18122687.
Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients.
Kim Y, Cho M, Kim J, Kim S, Oh S, Lee K
Oncotarget. 2017; 8(41):69888-69905.
PMID: 29050249
PMC: 5642524.
DOI: 10.18632/oncotarget.19435.
Quantification of topological features in cell meshes to explore E-cadherin dysfunction.
Mestre T, Figueiredo J, Ribeiro A, Paredes J, Seruca R, Sanches J
Sci Rep. 2016; 6:25101.
PMID: 27151223
PMC: 4858654.
DOI: 10.1038/srep25101.
Quantification of mutant E-cadherin using bioimaging analysis of in situ fluorescence microscopy. A new approach to CDH1 missense variants.
Sanches J, Figueiredo J, Fonseca M, Duraes C, Melo S, Esmenio S
Eur J Hum Genet. 2014; 23(8):1072-9.
PMID: 25388006
PMC: 4795115.
DOI: 10.1038/ejhg.2014.240.
Genomic profile analysis of diffuse-type gastric cancers.
Lee Y, Cho Y, Lee G, Lee S, Kim Y, Jho S
Genome Biol. 2014; 15(4):R55.
PMID: 24690483
PMC: 4056347.
DOI: 10.1186/gb-2014-15-4-r55.
Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
Garziera M, Canzonieri V, Cannizzaro R, Geremia S, Caggiari L, De Zorzi M
PLoS One. 2013; 8(10):e77035.
PMID: 24204729
PMC: 3812172.
DOI: 10.1371/journal.pone.0077035.
The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC.
Figueiredo J, Soderberg O, Simoes-Correia J, Grannas K, Suriano G, Seruca R
Eur J Hum Genet. 2012; 21(3):301-9.
PMID: 22850631
PMC: 3573198.
DOI: 10.1038/ejhg.2012.159.
E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer.
Simoes-Correia J, Figueiredo J, Lopes R, Stricher F, Oliveira C, Serrano L
PLoS One. 2012; 7(3):e33783.
PMID: 22470475
PMC: 3309996.
DOI: 10.1371/journal.pone.0033783.
ADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperones.
Figueiredo J, Simoes-Correia J, Soderberg O, Suriano G, Seruca R
PLoS One. 2011; 6(8):e23188.
PMID: 21853084
PMC: 3154279.
DOI: 10.1371/journal.pone.0023188.
PIPKIγ regulates β-catenin transcriptional activity downstream of growth factor receptor signaling.
Schramp M, Thapa N, Heck J, Anderson R
Cancer Res. 2011; 71(4):1282-91.
PMID: 21303971
PMC: 3066690.
DOI: 10.1158/0008-5472.CAN-10-2480.
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.
Schrader K, Masciari S, Boyd N, Salamanca C, Senz J, Saunders D
J Med Genet. 2010; 48(1):64-8.
PMID: 20921021
PMC: 3003879.
DOI: 10.1136/jmg.2010.079814.
Phosphoinositide signalling in cancer: beyond PI3K and PTEN.
Bunney T, Katan M
Nat Rev Cancer. 2010; 10(5):342-52.
PMID: 20414202
DOI: 10.1038/nrc2842.
Genetic screening for familial gastric cancer.
Oliveira C, Suriano G, Ferreira P, Canedo P, Kaurah P, Mateus R
Hered Cancer Clin Pract. 2010; 2(2):51-64.
PMID: 20233471
PMC: 2839995.
DOI: 10.1186/1897-4287-2-2-51.
Out, in and back again: PtdIns(4,5)P(2) regulates cadherin trafficking in epithelial morphogenesis.
Schill N, Anderson R
Biochem J. 2009; 418(2):247-60.
PMID: 19196245
PMC: 3740165.
DOI: 10.1042/BJ20081844.